Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
      • Research Guidelines
        • Minimum Information About Microarray Data Experiments (MIAME)
      • Abstract
      • Acknowledgments
      • Clinical Implications (Only by invitation)
      • Conflict(s) of Interest/Disclosure(s) Statement
      • Figure Legends
      • Figures
      • Novelty and Significance: 1) What Is New, 2) What Is Relevant?
      • References
      • Sources of Funding
      • Tables
      • Text
      • Title Page
      • Online/Data Supplement
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
      • Change of Authorship Form
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Hypertension

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Scientific Contributions

Contrasting Regression of Blood Pressure and Cardiovascular Structure in Declipped Renovascular Hypertensive Rats

Stinne Kvist, Michael J. Mulvany
Download PDF
https://doi.org/10.1161/01.HYP.0000054977.07679.59
Hypertension. 2003;41:540-545
Originally published March 1, 2003
Stinne Kvist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Mulvany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading

Abstract

We investigated the time relationship between changes in blood pressure and changes in the structure of the resistance vasculature. Blood pressure, heart/body weight ratio, and morphology and function of mesenteric resistance arteries from 1-kidney, 1-clip renovascular hypertensive rats were followed before and after declipping at age 14 weeks. The rats were divided into 5 groups, which were investigated 6 hours, 24 hours, 1 week, 4 weeks, and 8 weeks after declipping and compared with 2 normotensive and 2 renovascular hypertensive control groups at 14 weeks and 18 weeks. Systolic blood pressure was elevated 2 weeks after application of the clip and stabilized after 6 weeks. Declipping induced a prompt fall in blood pressure within 6 hours, and blood pressure was normalized within 1 week. Heart/body weight ratio was increased in renovascular hypertensive rats, and declipping induced a gradual decrease in the ratio, which was normalized within 4 weeks. Media/lumen ratio and media area of mesenteric resistance arteries were increased in renovascular hypertensive rats, and declipping did not affect media/lumen ratio and media area within 8 weeks, although there was a tendency for some regression of media/lumen ratio. There were no differences in response to high potassium, noradrenaline, or acetylcholine. Thus, these findings show definitively that declipping causes rapid reversal of renovascular hypertension in rats accompanied by gradual reduction of the heart/body weight ratio but lack of normalization in the mesenteric resistance vessels. This provides clear evidence that neither vascular nor cardiac structural changes are capable of keeping rats hypertensive.

  • hypertension, renal
  • rats
  • hypertrophy
  • arteries
  • blood pressure
  • heart
  • kidney
  • remodeling

Hypertension is complicated by hypertrophy of the heart and abnormal structure of peripheral arteries in renovascular hypertensive rats1 and spontaneously hypertensive rats (SHR),2 as well as in humans with essential3 or renovascular hypertension.4 Hypertension and the abnormal structure of the heart and vessels in SHR and essential hypertension can be reversed by pharmacological treatment,2,5–7 but the cause of the disease has not been treatable. In contrast, the cause of renovascular hypertension is known and can be removed and indeed appears to be the only way to normalize the blood pressure, as pharmacological treatment is difficult and seldom effective. Because the structural changes of heart and vessels occur in parallel with the high blood pressure in all forms of hypertension,8 it has been suggested that the structural changes may be one of the causes of hypertension, or at least contribute to the maintenance of hypertension.8,9 However, there are a number of reports indicating that after an intervention, vascular structure and pressure are not correlated.10,11 For example, when the renal artery stenosis is removed in 1-kidney, 1-clip (1K-1C) rats, blood pressure returns to normotensive levels almost immediately,12 whereas similar observations have been made concerning the angiotensin II infusion model of hypertension after cessation of infusion.13 In both cases, the rapidity of the blood pressure fall makes it likely that the fall occurs before any regression of resistance vessel structure,14–16 but there is no direct evidence on this point. Stacy and Prewitt16 found little change in cremaster arteriole structure either before or 4 weeks after declipping measured histologically, although in vivo measurements indicated that 1K-1C hypertension was associated with structural changes that partially regressed after declipping. Indirect evidence for slow regression of resistance vessel structure after declipping was obtained in perfusion experiments in the hindquarter preparation.15 Slow regression of heart weight after declipping has also been reported.14 We therefore decided to examine this question directly in the resistance vasculature and to test critically the hypothesis that blood pressure and resistance vessel structure are not necessarily correlated after an intervention that corrects hypertension. To address this hypothesis, the current study was performed in 1K-1C rats in which hypertension is pronounced17 and independent of renin.18 After development of a stable high blood pressure, we removed the clips and studied the time relationship of the regression of blood pressure, heart and kidney weight, and resistance artery morphology measured on a myograph from 6 hours to 8 weeks thereafter.

Methods

Materials

One hundred ninety-nine Male Wistar rats were received (5 weeks old) from Møllegaard Breeding Center, Lille Skensved, Denmark. An equilibration period for at least 4 days was allowed before the start of experimental procedures. The rats had free access to food and tap water except at the time of blood pressure measurements (see below). All rats were killed by exposure to CO2 for final studies.

Health status was supervised by the local animal welfare officer, and all experiments were performed according to Danish legislation.

Protocol for Grouping

The rats were divided into a normotensive, sham-operated group (sham) of 30 rats and a hypertensive 1K-1C group of 101 rats. All operations were performed in rats 6 to 7 weeks of age. The sham rats were subdivided in 2 groups with 15 rats in each, which were studied at 14 and 18 weeks of age, respectively. The 1K-1C rats were randomly subdivided into 7 groups: 2 groups with 15 rats in each, which served as hypertensive controls (control 1K-1C) at 14 and 18 weeks of age, respectively, and 5 groups that were declipped (declipped 1K-1C) at 14 weeks of age, and the rats were subsequently killed 6 hours (16 rats), 24 hours (14 rats), 1 week (16 rats), 4 weeks (15 rats), and 8 weeks (10 rats) after declipping.

Blood Pressure

Systolic blood pressure was measured by the tail-cuff method with a plethysmograph (LE5000, Lettica). Before measurements, rats were preheated for 20 to 30 minutes at 35°C in their cages. Rats were then moved to a small heated container, where the rats were trained to stay for periods up to 20 minutes. In each rat, 4 to 6 measurements were made and mean values were used. The equipment was calibrated every day by comparison with a mercury column.

Blood pressure measurements in 1K-1C rats were made before insertion of clips, 2 weeks after and every week hereafter until systolic blood pressure increased above 160 mm Hg. Afterward, blood pressure was measured in control 1K-1C rats at the time of killing, whereas in declipped 1K-1C it was measured just before declipping and at the time of killing. Blood pressure measurements in the sham rats took place just before sham operation and at the time of killing.

Preparation of Sham and 1K-1C Rats

Rats were anesthetized with 7 mg/kg IP methohexital, and, if necessary, supplemented with small doses of methohexital directly to the abdominal cavity during the operation. The fur was shaved off the abdomen and the operation was performed through a 4-cm longitudinal incision as described by Stacy and Prewitt.16 The left renal artery was dissected free of fat and connective tissue, and in animals chosen to be hypertensive, a U-shaped silver clip, 230- to 250-μm internal diameter, was placed around the renal artery as far from the kidney as possible. Afterward, the right kidney was removed and the incision was closed by suturing the muscular layer and by attaching wound clips to the skin. Sham rats were prepared by the same procedure as the 1K-1C rats apart from the application of a clip. In declipped rats, the clips were gently removed from 1K-1C rats after cleaning for adhesive tissue in an operation through the initial incision.

In Vitro Protocols

Dissection

After killing with exposure to CO2, the rat was weighed and heart, kidney, and a piece of the mesenteric vascular bed were cut out and placed in ice-cold physiological salt solution (PSS, see below for composition). The atria of the heart were cut away and the heart was wiped with paper and weighed. The kidney was cleaned from fat and connective tissue, wiped with paper, and weighed. From the mesenteric vascular bed, 2 segments of vessels from the third branch, 2 mm long and with an internal diameter of ≈230 μm, were dissected free from fat and mounted in a wire myograph.19 In the myograph, vessels were bubbled with 5% CO2 in air and allowed to equilibrate at 37°C for 30 minutes.

Morphometric Measurements

After equilibration, the myograph was placed on a microscope and wall structure was measured at 6 different positions by an ocular micrometer.20 Vessels were then set to normalized diameter, l1, that is, 0.9 times the internal diameter the vessels would have if fully relaxed and exposed to a transmural pressure of 100 mm Hg, calculated on the basis of the Laplace relation.19,21 Mean of media thickness and internal diameter was expressed as media/lumen ratio.

Functional Measurements

After normalization, vessels were exposed to PSS with potassium (K-PSS, see below for composition) for 2 minutes as a measure of contractile capacity. A concentration response curve to acetylcholine (10−8–10−5 mol/L) was performed on top of a precontraction with 3 μmol/L noradrenaline by adding the drug in half-logarithmic concentrations to the bath every second minute.

Exclusion Criteria

Rats were excluded from the study if (1) systolic blood pressure in rats with clips was below 165 mm Hg after 8 weeks; (2) systolic blood pressure in sham rats was above 140 mm Hg; (3) internal diameter of the vessels in the myograph was below 150 μm or above 350 μm; (4) active pressure response of the vessels [active wall tension/(l1/2)]21 to K-PSS for 2 minutes was below 13 kPa; (5) if renal scars caused by renal infarction were present at the time of killing.

Solutions and Drugs

Physiological salt solution consisted of (mmol/L): 119 NaCl, 4.7 KCl, 1.17 MgSO4,7H2O, 25 NaHCO3, 1.18 KH2PO4, 0.0026 EDTA, 5.5 glucose, and 1.6 CaCl2. In K-PSS, NaCl was replaced with equimolar KCl.

Drugs used were methohexital (Brietal7, Lilly), (−)noradrenaline hydrochloride (Sigma Chemicals Co), and acetylcholine (Fluka AG).

Data Analysis

Analysis was based on the mean of the 2 vessels taken from each animal. All values are given as mean±SEM. One-way ANOVA was used for comparisons between groups. If ANOVA showed a significant difference, data were analyzed by the Student 2-tailed, unpaired t test and linear regression for specified groups. A value of P<0.05 was considered significant.

Results

Basal Characteristics

After the application of the clips or sham operation at age 6 to 7 weeks old, 68 rats (34%) were lost as the result of uremia/malignant hypertension (n=46), rupture of the renal artery when declipping (n=8), anesthesia (n=6), infarction of the kidney (n=1), unknown reason (n=7), or exclusion according to the above exclusion criteria.15 This left 131 rats for investigation.

Before application of clips, the average weight of the rats was 163±3 g, and the average systolic blood pressure and heart rate were 116±1 mm Hg and 409±4 beats/min, respectively. There were no differences in the parameters between the groups.

Blood Pressure

The blood pressure of the 1K-1C rats was increased 2 weeks after application of clips and increased further until 6 weeks after application of clips. Afterward, the blood pressure remained stable. After declipping, there was an immediate fall in blood pressure to the control level within 6 hours. The blood pressure decreased further and reached the level of the sham rats 1 week after declipping. The blood pressure then remained stable until the end of follow-up at 22 weeks of age, 8 weeks after declipping. The blood pressure in the sham rats gradually increased between 6 and 7 weeks and 18 weeks of age (Figure 1). There were no differences in heart rate between any of the groups (data not shown). Mean heart rate for all groups was 409±4 beats/min.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. Time relationship of blood pressure after application of clips and after declipping. ○, 1K-1C rats before and after declipping; •, sham rats; ▪, control 1K-1C rats. Results are mean±SEM. ***P<0.001 vs age-matched control 1K-1C rats.

Heart, Kidney, and Body Weight

The weights of the kidney and the body of the 1K-1C rats were reduced compared with that in the sham rats at 14 weeks of age, but the differences had disappeared at 18 weeks of age, 4 weeks after declipping (Table 1). Kidney weight as a fraction of body weight was similar for all groups. The heart/body weight ratio was increased in 1K-1C rats at 14 weeks of age compared with sham rats. Between 14 and 18 weeks, there were no changes in the heart/body weight ratio in either the sham rats or in the control 1K-1C rats. In declipped 1K-1C rats, the heart/body ratio declined gradually and was significantly reduced after 1 week and not significantly different from sham rats within 4 weeks (Figure 2).

View this table:
  • View inline
  • View popup

TABLE 1. Weight of Body, Left Kidney, and Heart in SHAM, Control 1K-1C, and Declipped 1K-1C Rats

Figure2
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 2. Time relationship of heart/body weight ratio after declipping. ○, Declipped 1K-1C rats; •, sham rats; ▪, control 1K-1C rats. Results are mean±SEM. ***P<0.001 vs age-matched control 1K-1C rats.

Morphometric Characteristics of the Vessel Wall

The morphometric data are shown in Table 2 and Figure 3. When rats were 14 weeks old, 8 weeks after the application of clips, the media/lumen ratio of mesenteric resistance arteries was increased in the 1K-1C rats compared with the age-matched sham rats. There was no further increment in media/lumen ratio between 14 and 18 weeks of age, either for sham rats or control 1K-1C rats. Declipping did not induce regression of media/lumen ratio of mesenteric resistance arteries (ANOVA for declipped 1K-1C groups: P=0.11). Linear regression of media/lumen ratio of resistance arteries from declipped 1K-1C rats showed a tendency for regression (P=0.07).

View this table:
  • View inline
  • View popup

TABLE 2. Morphometric Measurements in Rat Mesenteric Resistance Vessels

Figure3
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 3. Time relationship of media/lumen ratio after declipping. ○, Declipped 1K-1C rats; •, sham rats; ▪, control 1K-1C rats. Results are mean±SEM. ***P<0.001 vs age-matched control 1K-1C rats. **P<0.01 vs age-matched declipped 1K-1C rats.

Media area and media thickness of the mesenteric resistance arteries were increased in the control 1K-1C rats compared with the sham rats at 14 and 18 weeks of age. There was no regression of media area and media thickness after declipping. There were no significant differences in internal diameter of arteries from sham rats, control 1K-1C rats, or declipped 1K-1C rats.

Functional Measurements

No functional differences were found (Table 3). Thus, there were no differences in maximal effect of acetylcholine between the sham, control 1K-1C, or declipped 1K-1C groups. The vessels relaxed by ≈65% of the noradrenaline preconstriction when exposed to acetylcholine in all groups. The acetylcholine concentration for half-maximal relaxation was similar in all groups (compared with 0.1 μmol/L, data not shown). There were no differences in contractile responses to noradrenaline and K-PSS between the groups.

View this table:
  • View inline
  • View popup

TABLE 3. Maximal Responses of Mesenteric Resistance Arteries to Acetylcholine (Relaxation) and to K-PSS and Noradrenaline (Contraction)

Discussion

The main finding of this study was that while declipping caused a rapid normalization of blood pressure, heart weight and resistance vessel morphology regressed either slowly or not at all.

Given the strong association between blood pressure and vascular structure, as discussed in the Introduction, it was surprising that the structure of the small arteries was not significantly regressed 8 weeks after declipping, despite normal pressure for almost the whole of this time. This is in apparent contrast to the relation seen in SHR. Here, for example, treatment of established hypertension with different vasodilator antihypertensive drugs for 8 to 12 weeks results in a gradual reduction of blood pressure and regression of cardiac hypertrophy22,23 and regression of abnormal structure of small resistance vessels.23,24 Similarly, in humans, successful treatment of essential hypertension with vasodilators causes regression of heart weight and resistance vessel structure, at least after 1 year.7,25,26 As described in the Introduction, the retarded regression of the hypertrophy of the heart despite fast normalization of blood pressure in renovascular hypertensive rats was also observed by Friberg and Nordborg14 and Lundgren,15 and similar findings were observed in the arterioles of the rat cremaster muscle by Stacy and Prewitt16 and indirectly in the hindquarter perfusion preparation by Lundgren.15 These indications of fast normalization of blood pressure and the retarded or absent regression of heart weight and resistance vessel structure in declipped renovascular hypertensive rats are now strongly supported by the direct investigations of the structure of the vessels in our experiments. It appears therefore to be a general finding in these animals that hypertrophy of vessels and heart are not able to keep blood pressure high, and any hypertensive action of the hypertrophy is eliminated either by removal of a vasoconstrictor agent or by activation of a vasodilator agent. The existence of such an agent has also been proposed by Muirhead et al,27 who provided evidence for an antihypertensive neutral renomedullary lipid, medullipin, suggested to be released from the declipped kidney.27,28

The divergence in the rates of normalization in blood pressure and cardiovascular structure seen in this study confirms other situations in which blood pressure and cardiovascular structure are not always tightly associated. Thus, although this tight association is normally seen in most forms of hypertension, as discussed above, specific interventions may interrupt this association. For example, treatment of SHR29 or of patients with essential hypertension patients with β-blockers30,31 causes blood pressure reduction without affecting small-artery structure. As another example, withdrawal of treatment, both in humans32 and in SHR,26 induces a rise in blood pressure that is not time-related to changes in resistance artery structure, and the data emphasize that abnormal vascular structure is not in itself sufficient to maintain a high blood pressure. As regards normalization of blood pressure, normalization of resistance vessel structure may not therefore be important. However, it cannot be excluded that abnormal structure may have other consequences, such as reduced vascular reserve33; further studies are, however, needed to establish this.

The role of the endothelium in hypertension has been investigated intensively, and the results in normotensive rats and hypertensive rats of different kinds are conflicting. However, as regards renovascular hypertensive rats, there has been general agreement that the response to acetylcholine is reduced (in 1K-1C as well as in 2K-1C rats) compared with normotensive rats.34–38 This is in contrast to our results that showed no differences in response to acetylcholine. We found no obvious reason for the conflicting results because the conditions we have used are in general similar, such that some subtle difference in our protocol probably accounts for the discrepancy.

It was of some concern that approximately one third of the animals did not survive the consequences of the operation, which we ascribed to the crucial importance of the clip aperture: Variations of ≈30 μm were found to span the difference between no hypertensive effects and induction of uremia.17 However, our finding that for the survivors after placement of the clip, blood pressure was elevated after 2 weeks and remained stable after 6 weeks is in agreement with the findings of Stacy and Prewitt.16 The hypertrophy of the heart and increased media/lumen ratio and media area of the resistance arteries is also in agreement with previous findings,39 as is the normalization of the weight of the clipped kidney after an initial weight reduction.17 The rapid fall in blood pressure within a few hours after declipping is also similar to that previously reported,40,41 although it took more than 1 day to normalize. The model thus appears to have been satisfactory.

Perspectives

This study has provided clear evidence that rapid reduction of blood pressure, achieved in this study by declipping of 1K-1C rats, is not necessarily accompanied by a corresponding normalization of resistance vessel structure over a period of 8 weeks, although heart weight was normalized after 4 weeks. This thus provides definitive evidence that an abnormal resistance vessel structure is not in itself sufficient to maintain a high blood pressure. Conversely, reduction of blood pressure does not in itself necessarily result in a rapid normalization of resistance vessel structure. As indicated, treatment of genetic hypertension does in some cases result in normalization of resistance vessel structure, but it is not known how quickly this occurs. Furthermore, some treatments of genetic hypertension do not normalize resistance vessel structure even after 1 year or more. Taken together with the results of the present study, this indicates a need for a better understanding of the mechanisms that allow normalization of resistance vessel structure in the treatment of hypertension. The results of this study also underline the need for understanding the degree to which an abnormal resistance vessel structure should be a target for antihypertensive therapy.

Acknowledgments

This study was supported by the Danish Heart Foundation, the Danish Society of Rheumatic Patients, the Danish Society of Nephrologic Patients, and the Danish Society of Hypertension. Michael Mulvany is supported by the Danish Medical Research Council. The authors are grateful for the technical assistance of Lotte Paaby.

  • Received July 24, 2002.
  • Revision received August 14, 2002.
  • Accepted December 18, 2002.

References

  1. ↵
    Lundgren Y, Hallback M, Weiss L, Folkow B. Rate and extent of adaptive cardiovascular changes in rats during experimental renal hypertension. Acta Physiol Scand. 1974; 91: 103–115.
    OpenUrlCrossRefPubMed
  2. ↵
    Li JS, Schiffrin EL. Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1996; 28: 68–74.
    OpenUrlCrossRefPubMed
  3. ↵
    Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: dual processes of remodeling and growth. Hypertension. 1993; 21: 391–397.
    OpenUrlFREE Full Text
  4. ↵
    Muiesan ML, Rizzoni D, Salvetti M, Porteri E, Monteduro C, Guelfi D, Castellano M, Garavelli G, Agabiti-Rosei E. Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension. J Hypertens. 2002; 20: 1439–1444.
    OpenUrlCrossRefPubMed
  5. ↵
    Devereux RB, Palmieri V, Sharpe N, De Quattro V, Bella JN, de Simone G, Walker JF, Hahn RT, Dahlof B. Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial. Circulation. 2001; 104: 1248–1254.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, Giulini SM, Agabiti-Rosei E. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension. 1996; 28: 785–790.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Schiffrin EL. Vascular changes in hypertension in response to drug treatment: effects of angiotensin receptor blockers. Can J Cardiol. 2002; 18 (suppl A): 15A-18A.
    OpenUrlPubMed
  8. ↵
    Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982; 62: 347–504.
    OpenUrlFREE Full Text
  9. ↵
    Korner PI, Bobik A. Cardiovascular development after enalapril in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension. 1995; 25: 610–619.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Mulvany MJ. Resistance vessel growth and remodelling: cause or consequence in cardiovascular disease. J Hum Hypertension. 1995; 9: 479–485.
    OpenUrlPubMed
  11. ↵
    Heagerty AM, Izzard AS. Small-artery changes in hypertension. J Hypertens. 1995; 13: 1560–1565.
    OpenUrlPubMed
  12. ↵
    Russell GI, Brice JM, Bing RF, Swales JD, Thurston H. Haemodynamic changes after surgical reversal of chronic two-kidney, one-clip hypertension in the rat. Clin Sci. 1981; 61 (suppl 7): 117s–119s.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Brown AJ, Casals-Stenzel J, Gofford S, Lever AF, Morton JJ. Comparison of fast and slow pressor effects of angiotensin II in the conscious rat. Am J Physiol. 1981; 241: H381–H388.
    OpenUrlPubMed
  14. ↵
    Friberg P, Nordborg C. Functional, morphological and metabolic characteristics of isolated hearts from normotensive and spontaneously hypertensive rats before, during and after renal hypertension. Acta Physiol Scand. 1986; 126: 161–171.
    OpenUrlPubMed
  15. ↵
    Lundgren Y. Regression of structural cardiovascular changes after reversal of experimental renal hypertension in rats. Acta Physiol Scand. 1974; 91: 275–285.
    OpenUrlPubMed
  16. ↵
    Stacy DL, Prewitt RL. Effects of chronic hypertension and its reversal on arteries and arterioles. Circ Res. 1989; 65: 869–879.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Murphy WR, Coleman TG, Smith TL, Stanek KA. Effects of graded renal artery constriction on blood pressure, renal artery pressure, and plasma renin activity in Goldblatt hypertension. Hypertension. 1984; 6: 68–74.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Skeggs LT, Kahn JR, Levine M, Dorer FE, Lentz KE. Chronic one-kidney hypertension in rabbits. I. treatment with kidney extracts. Circ Res. 1975; 37: 715–724.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977; 41: 19–26.
    OpenUrlFREE Full Text
  20. ↵
    Mulvany MJ, Hansen OK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res. 1978; 43: 854–864.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Buus NH, VanBavel E, Mulvany MJ. Differences in sensitivity of rat mesenteric small arteries to agonists when studied as ring preparations or as cannulated preparations. Br J Pharmacol. 1994; 112: 579–587.
    OpenUrlPubMed
  22. ↵
    Levy BI, Duriez M, Samuel JL. Coronary microvasculature alteration in hypertensive rats: effect of treatment with a diuretic and an ACE inhibitor. Am J Hypertens. 2001; 14: 7–13.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Sharifi AM, Li JS, Endemann D, Schiffrin EL. Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats. J Hypertens. 1998; 16: 457–466.
    OpenUrlCrossRefPubMed
  24. ↵
    Gillies LK, Lee RM. Effects of chronic blockade of angiotensin II receptor on the maintenance of hypertension and vascular changes in spontaneously hypertensive rats. Can J Physiol Pharmacol. 1996; 74: 1061–1069.
    OpenUrlCrossRefPubMed
  25. ↵
    Sihm I, Thygesen K, Krusell LR, Lederballe O. Long-term renal and cardiovascular effects of antihypertensive treatment regimens based upon isradipine, perindopril and thiazide. Blood Press. 2000; 9: 346–354.
    OpenUrlCrossRefPubMed
  26. ↵
    Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ. Dose-dependent effects of perindopril on blood pressure and small-artery structure. Hypertension. 1994; 23: 659–666.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Muirhead EE, Pitcock JA, Nasjletti A, Brown P, Brooks B. The antihypertensive function of the kidney: its elucidation by captopril plus unclipping. Hypertension. 1985; 7 (suppl I): I-127–I-135.
    OpenUrlPubMed
  28. ↵
    Thomas CJ, Woods RL, Evans RG, Alcorn D, Christy IJ, Anderson WP. Evidence for a renomedullary vasodepressor hormone. Clin Exp Pharmacol Physiol. 1996; 23: 777–785.
    OpenUrlPubMed
  29. ↵
    Christensen KL, Jespersen LT, Mulvany MJ. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. J Hypertens. 1989; 7: 83–90.
    OpenUrlPubMed
  30. ↵
    Schiffrin EL, Deng LY, Larochelle P. Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension. 1994; 23: 83–91.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Thybo N, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension. 1995; 25: 474–481.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    Korner PI, Bobik A, Jennings GL, Angus JA, Anderson WP. Significance of cardiovascular hypertrophy in the development and maintenance of hypertension. J Cardiovasc Pharmacol. 1991; 17 (suppl 2): S25–S32.
    OpenUrl
  33. ↵
    Strauer BE, Schwartzkopff B. Left ventricular hypertrophy and coronary microcirculation in hypertensive heart disease. Blood Press. 1997; 2 (suppl): 6–12.
    OpenUrlPubMed
  34. ↵
    Bennett MA, Thurston H. Effect of angiotensin-converting enzyme inhibitors on resistance artery structure and endothelium-dependent relaxation in two-kidney, one-clip Goldblatt hypertensive and sham-operated rats. Clin Sci (Colch). 1996; 90: 21–29.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    Lee BH, Shin HS. Interaction of nitric oxide and the renin angiotensin system in renal hypertensive rats. Jpn J Pharmacol. 1997; 74: 83–90.
    OpenUrlPubMed
  36. ↵
    Nakamura T, Prewitt RL. Alteration of endothelial function in arterioles of renal hypertensive rats at two levels of vascular tone. J Hypertens. 1992; 10: 621–627.
    OpenUrlPubMed
  37. ↵
    Ortenberg JM, Cook AK, Inscho EW, Carmines PK. Attenuated afferent arteriolar response to acetylcholine in Goldblatt hypertension. Hypertension. 1992; 19: 785–789.
    OpenUrlPubMed
  38. ↵
    Angus JA, Dyke AC, Jennings GL, Korner PI, Sudhir K, Ward JE, Wright CE. Release of endothelium-derived relaxing factor from resistance arteries in hypertension. Kidney Int. 1992; 41 (suppl 37): S73–S78.
    OpenUrl
  39. ↵
    Korsgaard N, Mulvany MJ. Cellular hypertrophy in mesenteric resistance vessels from renal hypertensive rats. Hypertension. 1988; 12: 162–167.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Byrom FB, Dodson LF. The mechanism of the vicious circle in chronic hypertension. Clin Sci. 1949; 8: 1–10.
    OpenUrlPubMed
  41. ↵
    ten Berg R, de Jong W. Time course of the enhanced blood pressure response to reinduction of renal artery stenosis in unclipped renal hypertensive rats. Pflugers Arch. 1979; 380: 133–137.
    OpenUrlPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Hypertension
March 2003, Volume 41, Issue 3
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Contrasting Regression of Blood Pressure and Cardiovascular Structure in Declipped Renovascular Hypertensive Rats
    Stinne Kvist and Michael J. Mulvany
    Hypertension. 2003;41:540-545, originally published March 1, 2003
    https://doi.org/10.1161/01.HYP.0000054977.07679.59

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Hypertension.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Contrasting Regression of Blood Pressure and Cardiovascular Structure in Declipped Renovascular Hypertensive Rats
    (Your Name) has sent you a message from Hypertension
    (Your Name) thought you would like to see the Hypertension web site.
  • Share on Social Media
    Contrasting Regression of Blood Pressure and Cardiovascular Structure in Declipped Renovascular Hypertensive Rats
    Stinne Kvist and Michael J. Mulvany
    Hypertension. 2003;41:540-545, originally published March 1, 2003
    https://doi.org/10.1161/01.HYP.0000054977.07679.59
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Hypertension

  • About Hypertension
  • Instructions for Authors
  • AHA CME
  • Guidelines and Statements
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
7272 Greenville Ave.
Dallas, TX 75231
email: hypertension@heart.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured